IL6 and COVID-19: Similar to COVID-19 patients, people infected with CMV usually have higher serum levels of IL-6.12 In contrast, the use of tocilizumab as a monoclonal antibody against IL-6 is effective in the treatment of COVID-19 patients in the intensive care unit.